
Mouse MMP-3 PicoKine ELISA Kit standard curve
Mouse MMP-3/Stromelysin-1 ELISA Kit PicoKine(r)
EK0462
ReactivityMouse
Product group Assays
Overview
- SupplierBoster Bio
- Product NameMouse MMP-3/Stromelysin-1 ELISA Kit PicoKine(r)
- Delivery Days Customer9
- ApplicationsELISA
- Applications SupplierELI
- Assay Detection Range156 pg/ml - 10,000 pg/ml
- Assay Sensitivity<10 pg/ml
- Assay Time20-25
- CertificationResearch Use Only
- Scientific DescriptionMouse MMP-3 ELISA Kit PicoKine® (96 Tests). Quantitate Mouse Mmp3 in cell culture supernatants, serum and plasma (heparin). Sensitivity: 10 pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
- ReactivityMouse
- Reactivity SupplierMouse MMP-3
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116158
References
- Li S, Hu G, Kuang L, et al. Unraveling the mechanism of ethyl acetate extract from Prismatomeris connata Y. Z. Ruan root in treating pulmonary fibrosis: insights from bioinformatics, network pharmacology, and experimental validation. Front Immunol. 2023,14:1330055. doi: 10.3389/fimmu.2023.1330055Read this paper
- Yang YP, Jian YQ, Liu YB, et al. Heilaohuacid G, a new triterpenoid from Kadsura coccinea inhibits proliferation, induces apoptosis, and ameliorates inflammation in RA-FLS and RAW 264.7 cells via suppressing NF-𝜅B pathway. Phytother Res. 2022,36(10):3900-3910. doi: 10.1002/ptr.7527Read this paper
- Chen CL, Zhang L, Jiao YR, et al. miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo. FEBS Lett. 2019,593(10):1089-1101. doi: 10.1002/1873-3468.13387Read this paper
- Wang J, Chen Y, Zhang C, et al. Learning and memory deficits and alzheimer's disease-like changes in mice after chronic exposure to microcystin-LR. J Hazard Mater. 2019,373:504-518. doi: 10.1016/j.jhazmat.2019.03.106Read this paper
